TRANSCARDIA Trademark

Trademark Overview

On Wednesday, March 16, 2022, a trademark application was filed for TRANSCARDIA with the United States Patent and Trademark Office. The USPTO has given the TRANSCARDIA trademark a serial number of 97314595. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 18, 2024. This trademark is owned by Transcardia, LLC. The TRANSCARDIA trademark is filed in the Computer & Software Services & Scientific Services, Medical & Beauty Services & Agricultural Services, Personal, and Legal & Social Services categories with the following description:

Regulatory compliance consulting, namely consulting in the field of regulatory affairs including for pharmaceuticals, therapies, and medical devices in the preclinical, clinical and commercial stage

Providing medical information, consultancy, and advisory services to medical professionals in the field of gene modification technology, organ transplants, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals and medical devices; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical evaluation services for patients of gene modification, organ transplants, xenotransplantation, regenerative medicine, and advanced therapies for purposes of guiding treatment and assessing effectiveness

Scientific and technological consulting services, namely, providing medical and scientific research information in the field of gene modification technology, organ transplants, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, and medical devices; Scientific and technological research, namely, providing information in the field of pharmaceutical preclinical and clinical research and development; quality management services, namely quality evaluation and analysis, quality assurance, and quality control in the field of gene modification technology, organ transplants, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, and medical device manufacturing; scientific research and development for medical purposes; compiling data for research purposes in the field of medical science and medical consultancy; design and testing for new...
transcardia

General Information

Serial Number97314595
Word MarkTRANSCARDIA
Filing DateWednesday, March 16, 2022
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 18, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 20, 2023

Trademark Statements

Goods and ServicesRegulatory compliance consulting, namely consulting in the field of regulatory affairs including for pharmaceuticals, therapies, and medical devices in the preclinical, clinical and commercial stage
Goods and ServicesProviding medical information, consultancy, and advisory services to medical professionals in the field of gene modification technology, organ transplants, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals and medical devices; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical evaluation services for patients of gene modification, organ transplants, xenotransplantation, regenerative medicine, and advanced therapies for purposes of guiding treatment and assessing effectiveness
Goods and ServicesScientific and technological consulting services, namely, providing medical and scientific research information in the field of gene modification technology, organ transplants, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, and medical devices; Scientific and technological research, namely, providing information in the field of pharmaceutical preclinical and clinical research and development; quality management services, namely quality evaluation and analysis, quality assurance, and quality control in the field of gene modification technology, organ transplants, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, and medical device manufacturing; scientific research and development for medical purposes; compiling data for research purposes in the field of medical science and medical consultancy; design and testing for new product development relating to the aforementioned services

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, March 21, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, March 21, 2022
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, April 5, 2023
Primary Code045
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTranscardia, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressNew Bern, NC 28562
Party NameTranscardia, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNew Bern, NC 28562

Trademark Events

Event DateEvent Description
Monday, March 18, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 18, 2024ABANDONMENT - NO USE STATEMENT FILED
Tuesday, August 15, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 20, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 20, 2023PUBLISHED FOR OPPOSITION
Wednesday, May 31, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, May 15, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 5, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 4, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 4, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 13, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, January 13, 2023NON-FINAL ACTION E-MAILED
Friday, January 13, 2023NON-FINAL ACTION WRITTEN
Wednesday, December 28, 2022ASSIGNED TO EXAMINER
Monday, March 21, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, March 19, 2022NEW APPLICATION ENTERED

Related Keywords

transcardia medical advanced field therapies services research medicine regenerative transplants organ